Pyxis Oncology Statistics Share Statistics Pyxis Oncology has 61.95M
shares outstanding. The number of shares has increased by 4.25%
in one year.
Shares Outstanding 61.95M Shares Change (YoY) 4.25% Shares Change (QoQ) 0.58% Owned by Institutions (%) 49.47% Shares Floating 44.02M Failed to Deliver (FTD) Shares 2,390 FTD / Avg. Volume 0.48%
Short Selling Information The latest short interest is 4.78M, so 7.72% of the outstanding
shares have been sold short.
Short Interest 4.78M Short % of Shares Out 7.72% Short % of Float 9.34% Short Ratio (days to cover) 10.86
Valuation Ratios The PE ratio is -1.18 and the forward
PE ratio is -0.88.
Pyxis Oncology's PEG ratio is
0.04.
PE Ratio -1.18 Forward PE -0.88 PS Ratio 5.65 Forward PS 10.4 PB Ratio 0.76 P/FCF Ratio -1.57 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Pyxis Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.49,
with a Debt / Equity ratio of 0.17.
Current Ratio 7.49 Quick Ratio 7.49 Debt / Equity 0.17 Debt / EBITDA -0.31 Debt / FCF -0.35 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $366.95K Profits Per Employee $-1.76M Employee Count 44 Asset Turnover 0.1 Inventory Turnover n/a
Taxes Income Tax -2.16M Effective Tax Rate 2.72%
Stock Price Statistics The stock price has increased by -68.84% in the
last 52 weeks. The beta is 1.13, so Pyxis Oncology's
price volatility has been higher than the market average.
Beta 1.13 52-Week Price Change -68.84% 50-Day Moving Average 1.19 200-Day Moving Average 1.6 Relative Strength Index (RSI) 41.02 Average Volume (20 Days) 496,683
Income Statement In the last 12 months, Pyxis Oncology had revenue of 16.15M
and earned -77.33M
in profits. Earnings per share was -1.32.
Revenue 16.15M Gross Profit 15.67M Operating Income -89.46M Net Income -77.33M EBITDA -65.51M EBIT -68.5M Earnings Per Share (EPS) -1.32
Full Income Statement Balance Sheet The company has 19.47M in cash and 20.2M in
debt, giving a net cash position of -727K.
Cash & Cash Equivalents 19.47M Total Debt 20.2M Net Cash -727K Retained Earnings -363.56M Total Assets 135.87M Working Capital 97.44M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -57.67M
and capital expenditures -237K, giving a free cash flow of -57.91M.
Operating Cash Flow -57.67M Capital Expenditures -237K Free Cash Flow -57.91M FCF Per Share -0.99
Full Cash Flow Statement Margins Gross margin is 97.06%, with operating and profit margins of -554.07% and -478.95%.
Gross Margin 97.06% Operating Margin -554.07% Pretax Margin -492.35% Profit Margin -478.95% EBITDA Margin -405.76% EBIT Margin -554.07% FCF Margin -358.66%
